[go: up one dir, main page]

NO992282L - Benzonaftyridiner som bronkialterapentika - Google Patents

Benzonaftyridiner som bronkialterapentika

Info

Publication number
NO992282L
NO992282L NO992282A NO992282A NO992282L NO 992282 L NO992282 L NO 992282L NO 992282 A NO992282 A NO 992282A NO 992282 A NO992282 A NO 992282A NO 992282 L NO992282 L NO 992282L
Authority
NO
Norway
Prior art keywords
pct
benzonaphthyridines
bronchial
therapies
date
Prior art date
Application number
NO992282A
Other languages
English (en)
Other versions
NO992282D0 (no
NO312764B1 (no
Inventor
Beate Gutterer
Wolf-R Giger Ulrich
Thomas Martin
Thomas Bor
Hermann Amschler
Dietrich Hofner
Armin Hatzelmann
Hans-Peter Kley
Karl Sanders
Karl-Josef Goebel
Rolf Beume
Dieter Flockerzi
Hildegard Boss
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of NO992282D0 publication Critical patent/NO992282D0/no
Publication of NO992282L publication Critical patent/NO992282L/no
Publication of NO312764B1 publication Critical patent/NO312764B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO19992282A 1996-11-11 1999-05-11 Benzonaftyridiner som bronkialterapeutika NO312764B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19646298 1996-11-11
EP96118188 1996-11-13
DE19739056 1997-09-05
PCT/EP1997/006096 WO1998021208A1 (en) 1996-11-11 1997-11-05 Benzonaphthyridines as bronchial therapeutics

Publications (3)

Publication Number Publication Date
NO992282D0 NO992282D0 (no) 1999-05-11
NO992282L true NO992282L (no) 1999-05-11
NO312764B1 NO312764B1 (no) 2002-07-01

Family

ID=27216810

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19992282A NO312764B1 (no) 1996-11-11 1999-05-11 Benzonaftyridiner som bronkialterapeutika

Country Status (30)

Country Link
US (1) US6008215A (no)
EP (1) EP0937074B1 (no)
JP (1) JP4223075B2 (no)
KR (1) KR100484045B1 (no)
CN (1) CN1090188C (no)
AT (1) ATE234300T1 (no)
AU (1) AU733129B2 (no)
BG (1) BG63695B1 (no)
BR (1) BR9713338B1 (no)
CA (1) CA2270964C (no)
CY (1) CY2476B1 (no)
CZ (1) CZ288752B6 (no)
DE (1) DE69719778T2 (no)
DK (1) DK0937074T3 (no)
EA (1) EA001551B1 (no)
EE (1) EE03829B1 (no)
ES (1) ES2195189T3 (no)
GE (1) GEP20012390B (no)
HU (1) HU226981B1 (no)
ID (1) ID22042A (no)
IL (1) IL129054A (no)
NO (1) NO312764B1 (no)
NZ (1) NZ334976A (no)
PL (1) PL189641B1 (no)
PT (1) PT937074E (no)
RS (1) RS49607B (no)
SI (1) SI0937074T1 (no)
SK (1) SK283269B6 (no)
TR (1) TR199900856T2 (no)
WO (1) WO1998021208A1 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306869B1 (en) 1998-05-05 2001-10-23 Byk Gulden Lomberg Chemische Febrik Gmbh N-oxides
ES2224745T3 (es) 1998-08-31 2005-03-01 Altana Pharma Ag N-oxidos de benzonaftiridina con actividad inhibidora de pde3 y pde4.
IT1303272B1 (it) 1998-10-29 2000-11-06 Zambon Spa Derivati triciclici inibitori della fosfodiesterasi 4
DK1147089T3 (da) * 1999-01-15 2006-04-10 Altana Pharma Ag Phenylphenanthridiner med PDE-IV-inhiberende virkning
CA2359449A1 (en) 1999-01-15 2000-07-20 Beate Gutterer Phenanthridine-n-oxides with pde-iv inhibiting activity
WO2000042017A1 (en) * 1999-01-15 2000-07-20 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridine-n-oxides with pde-iv inhibiting activity
AU2904300A (en) * 1999-01-15 2000-08-01 Byk Gulden Lomberg Chemische Fabrik Gmbh Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity
AU777012B2 (en) * 1999-08-21 2004-09-30 Takeda Gmbh Synergistic combination of PDE inhibitors and beta 2 adrenoceptor agonist
NL1017973C2 (nl) * 2000-05-10 2002-11-08 Tristem Trading Cyprus Ltd Inrichting.
DK1377574T3 (da) 2001-02-21 2005-04-25 Altana Pharma Ag 6-phenylbenzonaphtyridiner
US6479493B1 (en) 2001-08-23 2002-11-12 Cell Pathways, Inc. Methods for treatment of type I diabetes
WO2004018465A2 (en) * 2002-08-17 2004-03-04 Altana Pharma Ag Benzonaphthyridines with pde 3/4 inhibiting activity
US7470704B2 (en) 2002-09-04 2008-12-30 Nycomed Gmbh Benzonaphthyridines
PL373989A1 (en) * 2002-09-04 2005-09-19 Altana Pharma Ag Novel benzonaphthyridines
JP2006522151A (ja) 2003-04-01 2006-09-28 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ 不妊症におけるホスホジエステラーゼ阻害剤
AR049419A1 (es) * 2004-03-03 2006-08-02 Altana Pharma Ag Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo
CN104761545A (zh) 2004-03-03 2015-07-08 塔科达有限责任公司 新的羟基-6-杂芳基菲啶及其作为pde4抑制剂的用途
BRPI0508481A (pt) * 2004-03-10 2007-07-31 Altana Pharma Ag hidróxi-6-fenilenantridinas amido-substituìdas e seu uso como inibidores de pde4
CA2559200A1 (en) 2004-03-17 2005-09-29 Altana Pharma Ag Novel n- (alkoxyalkyl) carbamoyl - substituted 6-phenyl-benzonaphthyridine derivatives and their use as pde3/4 inhibitors
JP4960870B2 (ja) * 2004-09-08 2012-06-27 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規の3−チア−10−アザ−フェナントレン誘導体
WO2006027344A2 (en) * 2004-09-08 2006-03-16 Altana Pharma Ag 3-oxa-10-aza-phenanthrenes as pde4 or pde3/4 inhibitors
NZ589278A (en) 2005-03-02 2012-04-27 Nycomed Gmbh Selected salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives
WO2007045979A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
TW200808695A (en) * 2006-06-08 2008-02-16 Amgen Inc Benzamide derivatives and uses related thereto
ES2528316T3 (es) * 2006-09-01 2015-02-06 Senhwa Biosciences, Inc. Moduladores de la serina-treonina proteína quinasa y de PARP
CN112079769A (zh) 2008-04-23 2020-12-15 里格尔药品股份有限公司 用于治疗代谢障碍的甲酰胺化合物
AR079451A1 (es) 2009-12-18 2012-01-25 Nycomed Gmbh Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
CN108299429B (zh) * 2018-04-09 2021-10-08 中南大学 一类八氢苯并萘啶化合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899494A (en) * 1970-05-13 1975-08-12 Sandoz Ltd Substituted 6-phenyl benzo-naphthyridines
EP0247971A3 (en) * 1986-05-29 1990-01-17 Sandoz Ag Novel pharmaceutical compositions comprising and use of cis-6-(4-acetanilido)-8,9-dimethoxy-2-methyl-1,2,3,4,4a,10b-hexahydrobenzo[c][1,6]naphthyridin
MY105344A (en) * 1990-05-16 1994-09-30 Byk Gulden Lomberg Chemische Fabrik New sulphonyl compounds

Also Published As

Publication number Publication date
EE03829B1 (et) 2002-08-15
WO1998021208A1 (en) 1998-05-22
AU733129B2 (en) 2001-05-10
CA2270964A1 (en) 1998-05-22
ATE234300T1 (de) 2003-03-15
HUP0000426A2 (hu) 2001-02-28
YU19499A (sh) 2001-09-28
DE69719778T2 (de) 2004-02-05
BG63695B1 (bg) 2002-09-30
IL129054A (en) 2002-07-25
NO992282D0 (no) 1999-05-11
GEP20012390B (en) 2001-03-25
EA001551B1 (ru) 2001-04-23
NO312764B1 (no) 2002-07-01
TR199900856T2 (xx) 1999-07-21
EE9900105A (et) 1999-10-15
SK283269B6 (sk) 2003-04-01
RS49607B (sr) 2007-06-04
BR9713338A (pt) 2000-05-09
KR100484045B1 (ko) 2005-04-20
HK1022151A1 (en) 2000-07-28
HU226981B1 (hu) 2010-04-28
US6008215A (en) 1999-12-28
DK0937074T3 (da) 2003-06-23
PL333429A1 (en) 1999-12-06
PL189641B1 (pl) 2005-09-30
KR20000053100A (ko) 2000-08-25
EP0937074A1 (en) 1999-08-25
IL129054A0 (en) 2000-02-17
HUP0000426A3 (en) 2001-04-28
SK62399A3 (en) 1999-10-08
ES2195189T3 (es) 2003-12-01
CA2270964C (en) 2007-07-31
JP4223075B2 (ja) 2009-02-12
PT937074E (pt) 2003-07-31
CY2476B1 (en) 2005-05-03
AU5317098A (en) 1998-06-03
JP2001503442A (ja) 2001-03-13
DE69719778D1 (de) 2003-04-17
EP0937074B1 (en) 2003-03-12
CN1090188C (zh) 2002-09-04
BR9713338B1 (pt) 2009-12-01
EA199900421A1 (ru) 1999-10-28
NZ334976A (en) 2000-10-27
CZ167599A3 (cs) 1999-11-17
CN1236367A (zh) 1999-11-24
ID22042A (id) 1999-08-26
CZ288752B6 (cs) 2001-08-15
SI0937074T1 (en) 2003-08-31
BG103310A (en) 2000-05-31

Similar Documents

Publication Publication Date Title
NO992282L (no) Benzonaftyridiner som bronkialterapentika
BR9707233A (pt) Fenantridinas
DK0998460T3 (da) Hidtil ukendte tetrazolderivater
DK0544819T3 (da) Indolderivater, som inhiberer leukotrienbiosyntese
DK0889886T3 (da) Hidtil ukendte, i 6-stilling substituerede phenanthridiner
DK0772610T3 (da) Dihydrobenzofuraner
TR200100672T2 (tr) Yeni izoksazolinon antibakteriyel ajanları
DE69719358D1 (de) Substituierte dihydrobenzofurane als pde-hemmstoffe
PT920426E (pt) Novos derivados de tiazole com efeito inibidor de fosfodiesterase
DE60025327D1 (de) 6-arylphenanthridine mit pde-iv hemmender wirkung
DK1204659T3 (da) Serotonerge benzofuraner
TR200100133T2 (tr) FKBP İnhibitörleri
ATE163402T1 (de) Substituierte ortho- ethenylphenylessigsäurederivate
DK0912568T3 (da) Imidazopyridiner
SI0937075T1 (en) New Imidazo- and Oxazolopyridines as Phosphodiesterase Inhibitors.
PT1075476E (pt) Novos benzimidazoles e benzoxazoles

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA GMBH, DE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA GMBH, DE

MM1K Lapsed by not paying the annual fees